Peptron, Inc is a company operating in the pharmaceutical industry. The company specializes in anti-cancer technology, treatments for Parkinson's disease, and the development of antibiotic medicines. It provides peptide synthesis services and adheres to ISO9001 certified quality management standards. Peptron, Inc is currently engaged in clinical trials for its therapeutic drug pipeline and reported a revenue of $460 million from a recent contract, with total milestone technical fees reaching $539 million.
Headquarters
37-24, Yuseong-Daero, 1628Beon-Gil, Yuseong-Gu
Daejeon; Daejeon;
Contact Details: Purchase the Peptron Inc. report to view the information.
Website: http://www.peptron.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service